Fake Monupiravir found in Mexico 1 week after drug approval

Just a week after authorities approved the drug to treat patients at risk for severe COVID-19, Mexico has seen black market or counterfeit versions of monupavir circulated


MEXICO CITY — Mexico said on Friday it had seen black market or counterfeit versions of monupiravir circulated for sale, just a week after authorities approved the drug to treat people at risk of severe COVID-19.



The Mexican government last week approved Merck & Co’s molnupiravir for adults with COVID-19 and “high risk of complications.” On Friday, the agency approved Pfizer’s second drug, Paxlovid, for adult patients “at risk of complications.”

Mexico has long been plagued by counterfeit medicines, corruption within regulators and a preference for self-medication due to the country’s inadequate healthcare infrastructure.


Mexico has conducted few tests, and while the number of COVID-19 deaths confirmed by testing hovers around 300,000, a government review of death certificates suggests the actual toll is around 460,000.

.